SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biopsys Medical Inc – ‘10-Q’ for 9/30/96 – EX-11.1

As of:  Tuesday, 11/12/96   ·   For:  9/30/96   ·   Accession #:  912057-96-25361   ·   File #:  0-28016

Previous ‘10-Q’:  None   ·   Next:  ‘10-Q’ on 2/12/97 for 12/31/96   ·   Latest:  ‘10-Q’ on 5/5/97 for 3/31/97

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/12/96  Biopsys Medical Inc               10-Q        9/30/96    3:25K                                    Merrill Corp/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                      12     47K 
 2: EX-11.1     Statement re: Computation of Earnings Per Share        1      5K 
 3: EX-27       Exhibit 27 FDS                                         2      8K 


EX-11.1   —   Statement re: Computation of Earnings Per Share

EX-11.1TOCTopPreviousNextBottomJust 1st
 

EXHIBIT 11.1 BIOPSYS MEDICAL, INC. STATEMENT RE: COMPUTATION OF NET LOSS PER SHARE Three Months Ended September 30, ---------------------------------- 1996 1995 ------------- ------------ Net loss $ (138,000) $ (616,000) ------------ ------------ ------------ ------------ Shares used in computing net loss per share: Weighted average common shares outstanding during the period 9,716,880 1,785,000 Equivalent shares representing shares issuable upon conversion of preferred stock and preferred warrants: Series A - 833,333 Series B - 1,333,333 Series C - 3,051,590 Series C warrants - 32,624 Shares related to Staff Accounting Bulletin Topic 4D 556,902 556,902 ------------ ------------ Total shares used in computing historical net loss per share 10,273,782 7,592,782 ------------ ------------ ------------ ------------ Net loss per share $ (0.01) $ (0.08) ------------ ------------ ------------ ------------ 13
Top
Filing Submission 0000912057-96-025361   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 16, 3:52:57.1pm ET